Collaboration informs coronavirus policy by analyzing data associated with the pandemic
collaboration informs coronavirus policy by analyzing data associated with the pandemic The COVID-19 pandemic continues to challenge how societies and […]
By now, we’re all familiar with the immense strain the COVID-19 pandemic has placed on our health care system, with […] Corona App: RKI asks for data from fitness bracelets and Smartwatches Digital technologies can play in the containment of infections […] While gun violence in America kills more than 35,000 people a year and as calls for policies to stem the […] Cancer cardiovascular diseases as the main cause of death. This is a result of two studies presented on Tuesday at […] London UK – 19 March 2019 — TESARO, an oncology-focused business acquired by GlaxoSmithKline plc (LSE/NYSE: GSK), announced today the presentation […] Prompted by a call from the National Academy of Medicine, then the Institute of Medicine, for improved national data on […] Fitbits are putting a strain on doctors ‘because the exercise trackers are incorrectly telling wearers they are ILL’ Health apps […] NEWTON, Mass, Dec. 01, 2018 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today reported positive top-line […] Two teams of researchers have independently published papers describing research conducted using the full set of data in the UK […]data
The full picture: Why we need more demographic data on COVID-19
Corona-the App collects data from fitness bracelets and Smartwatches, Naturopathy, naturopathic specialist portal
To reduce gun violence, lift roadblocks to firearm data
Cancer is the most common cause of death in rich countries – how you can reduce your risk by 40 percent
Data From GARNET Study Indicates Robust Activity of Dostarlimab in Patients with Advanced or Recurrent Endometrial Cancer
Two decades of data reveal overall increase in pain, opioid use among U.S. adults
Fitbit users ‘are piling extra pressure on the NHS’
Karyopharm Reports Positive Top-Line Phase 2b SADAL Data for Selinexor in Patients with Diffuse Large B-Cell Lymphoma at the American Society of Hematology 2018 Annual Meeting
First two papers based on studies using full set of data in the UK Biobank published